← k3vl4r
Log inGet started →

ALXO (Alx Oncology Holdings Inc) Price Forecast

AI-generated price forecast for Alx Oncology Holdings Inc (ALXO) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads ALXO as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 1.24. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

1.24

AI outlook

2/2 bullish · STRONG

Timeframes up

2 / 2

Share𝕏PostTelegram

ALXO forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▲ Up+50.66%100%
Weekly~1.7 years out▲ Up+614.99%—

Latest ALXO news

From the market-news feed the forecasts are read against.

  • ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer · Yahoo · Sep 28
  • ALX Oncology Holdings Announces Publication Of Clinical Data From Its ASPEN-06 Randomized Phase 2 Clinical Trial In Nature Medicine, Showing Durable Clinical Benefit With Evorpacept In HER2-Positive Gastric Cancer · Benzinga · Sep 28

🔒

See the full ALXO forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ALXO forecast — frequently asked

Will ALXO go up?

K3vl4r's AI model currently reads ALXO as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ALXO price prediction for 2026?

K3vl4r's model projects ALXO toward $1.23 over the next ~3 months, a +0.5% move from $1.22. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could ALXO reach?

Over its longest horizon (~~1.7 years), the model's projected target for ALXO is $1.30 (+6.1% vs $1.22). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CRMDOSURZBIOZVRAINDPQNCXATECEWTXCPHIPROKGRCEIARTPTGXSNN

Will ALXO reach…?

Will ALXO reach $2.00?Will ALXO reach $3.00?Will ALXO reach $5.00?

Or see the full ALXO price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ALXO

ALXO vs CRMDALXO vs OSURALXO vs ZBIOALXO vs ZVRAALXO vs INDPALXO vs QNCX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.